In the current study, we showed that 5-azacytidine epigenetic priming improved platinum-based salvage chemotherapy in DLBCL via ERV-induced cGAS-STING activation rather than via dsRNA sensor activation. The gene discussed is STING1; the disease is diffuse large B-cell lymphoma.